Stem cell regulators

To characterize transcriptional regulation in human embryonic stem cells Richard Young at the Whitehead Institute and colleagues used a genome-wide analysis with chromatin immunoprecipitation and DNA microarrays, finding that transcription factors OCT4, SOX2, and NANOG target 353 genes, roughly half of which are not expressed. They also found that the three transcription factors co-occupy genes' promoter regions to regulate each others' activity.

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

L. Boyer et al., "Core transcriptional regulatory circuitry in human embryonic stem cells," Cell , 122:947-56, 2005. (Cited in 173 papers) [PUBMED]

The finding:

To characterize transcriptional regulation in human embryonic stem cells Richard Young at the Whitehead Institute and colleagues used a genome-wide analysis with chromatin immunoprecipitation and DNA microarrays, finding that transcription factors OCT4, SOX2, and NANOG target 353 genes, roughly half of which are not expressed. They also found that the three transcription factors co-occupy genes' promoter regions to regulate each others' activity.

The significance:

The study suggests these transcription factors repress genes involved in cell differentiation, which means they might play a role in maintaining embryonic stem cell self-renewal, says Tony Lee, also at the Whitehead and one of the paper's authors. It also suggests that unexpressed genes are repressed but poised for activation during development, says Angie Rizzino, at the University of Nebraska ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies